EmPowerPutida · Project

Engineered Bacteria That Produce Industrial Chemicals From Sugar Instead of Oil

manufacturingPrototypeTRL 4

Imagine a tiny factory — a single bacterium — that eats sugar and spits out chemicals we normally extract from crude oil. That's what this project did with Pseudomonas putida, a naturally tough microbe. The team re-wired its metabolism so it converts glucose into building-block chemicals like butanol and butadiene, and even a potential new herbicide. Think of it as teaching bacteria to do chemistry that currently requires a petrochemical plant.

By the numbers

EUR 6,020,825

EU funding for development of engineered Pseudomonas putida platform

Consortium partners across 6 countries

Industrial partners in the consortium (50% industry ratio)

Transcriptional/post-transcriptional genetic control devices developed

up to 10

Stable genetic insertions in the genome-edited P. putida chassis

Total project deliverables completed

The business problem

What needed solving

Chemical manufacturers depend on petroleum feedstocks to produce key building-block chemicals like butanol and butadiene, leaving them exposed to oil price volatility and tightening emissions regulations. At the same time, agrochemical companies face growing resistance to existing herbicides and need new active ingredients. Both industries need cost-competitive biological production routes that can replace or supplement petrochemistry.

The solution

What was built

The project built engineered Pseudomonas putida bacterial strains optimized for industrial chemical production. Concrete deliverables include: alcohol-resistant strains for producing short-chain alcohols, a deeply genome-edited chassis organism with up to 10 stable genetic insertions, and a toolkit of approximately 5 genetic control devices for switching cellular functions on and off. These components form a modular microbial production platform.

Audience

Who needs this

Specialty chemical companies producing butanol or butadiene from petroleumAgrochemical firms developing next-generation herbicide active ingredientsIndustrial biotechnology companies building microbial cell factoriesBioplastics manufacturers using fermentation-based productionSynthetic biology startups needing robust chassis organisms

Business applications

Who can put this to work

Specialty & Bulk Chemicals

enterprise

Target: Chemical manufacturers producing butanol, butadiene, or C4 platform chemicals from petroleum feedstocks

If you are a chemical manufacturer spending heavily on petroleum-based feedstocks for butanol or butadiene production — this project developed engineered Pseudomonas putida strains that produce these same chemicals from glucose. The strains decouple energy generation from growth, meaning more of the sugar goes into product rather than bacterial biomass. The consortium included 5 industrial partners across 6 countries validating the approach.

Crop Protection & Agrochemicals

mid-size

Target: Agrochemical companies developing herbicide alternatives

If you are an agrochemical company searching for new herbicide active ingredients — this project engineered a biological route to tabtoxin, a ß-lactam-based secondary metabolite with herbicidal properties. Instead of chemical synthesis, the bacterium produces it via fermentation from glucose. With 10 consortium partners including 2 SMEs, the platform was designed for plug-in production of new compounds.

Industrial Biotechnology & Bioplastics

any

Target: Bioplastics or biomaterials companies using fermentation

If you are a bioplastics company working with microbial fermentation and struggling with strain performance or product yields — this project built a deeply genome-edited Pseudomonas putida chassis with up to 10 stable genetic insertions and around 5 transcriptional control devices. The platform strain offers improved ATP availability and stress tolerance for producing compounds that are difficult to make in standard lab organisms like E. coli.

Frequently asked

Quick answers

What would it cost to license or adopt this technology?

The project does not publish licensing terms. With EUR 6,020,825 in EU funding and 10 consortium partners including 5 industrial ones, licensing would need to be negotiated directly with the consortium lead, Wageningen University. Costs would depend on whether you need the base strain, specific genetic devices, or a full production pathway.

Can this scale to industrial production volumes?

The project delivered lab-validated strains and genetic tools, not industrial-scale fermentation processes. However, the consortium's 50% industry ratio (5 out of 10 partners) and focus on bulk chemicals like butanol and butadiene suggest the work was designed with industrial scale-up in mind. A pilot fermentation phase would still be required before commercial production.

Who owns the intellectual property?

IP is shared among the 10 consortium partners across 6 countries (CH, DE, ES, NL, PT, UK) under Horizon 2020 rules. Wageningen University coordinated the project. Specific patents on the engineered strains, genetic devices, or production pathways would need to be checked with the coordinator.

Is this technology ready to use today?

The project closed in April 2019 and delivered prototype strains and genetic tools — not a turnkey production process. The engineered P. putida strains with genome edits and transcriptional control devices are research-grade outputs. Additional development and scale-up work would be needed before commercial deployment.

How does this compare to existing chemical production methods?

Traditional butanol and butadiene production relies on petroleum cracking. This bio-based route uses glucose as feedstock and Pseudomonas putida as the production organism. The key advantage is the decoupling of ATP synthesis from growth, which in principle directs more energy toward product formation rather than bacterial reproduction.

What regulatory approvals would be needed?

Any industrial use of genetically modified Pseudomonas putida strains would require regulatory approval under EU GMO contained-use regulations. The tabtoxin herbicide application would additionally need plant protection product authorization. Based on available project data, no regulatory submissions were made during the project period.

What concrete results came out of this project?

The project delivered 8 total deliverables including short-chain alcohol-resistant Pseudomonas strains, a deeply genome-edited P. putida host with up to 10 stable genetic insertions, and a suite of approximately 5 transcriptional/post-transcriptional genetic control devices. These are building blocks for a customizable microbial production platform.

Consortium

Who built it

The EmPowerPutida consortium is well-balanced for a research project aiming at industrial relevance: 10 partners from 6 countries (CH, DE, ES, NL, PT, UK), with a 50/50 split between industry (5 partners including 2 SMEs) and academia/research (4 universities, 1 research org). Wageningen University in the Netherlands leads the project. The strong industry presence — unusual for a basic research action — signals genuine commercial interest in the Pseudomonas putida platform. The EUR 6,020,825 budget spread across this consortium gave each partner meaningful resources to contribute. The geographic spread covers major European biotech hubs in Germany, the Netherlands, Spain, and the UK.

WAGENINGEN UNIVERSITYCoordinator · NL
LIFEGLIMMER GMBHparticipant · DE
ABENGOA RESEARCH SLparticipant · ES
INGENZA LIMITEDparticipant · UK
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICASparticipant · ES
UNIVERSIDADE NOVA DE LISBOAparticipant · PT
BASF SEparticipant · DE
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICHparticipant · CH
UNIVERSITY OF STUTTGARTparticipant · DE

How to reach the team

Wageningen University (Netherlands) — contact the industrial biotechnology or bioprocess engineering department

Order a report on this consortium See WAGENINGEN UNIVERSITY profile →

Next steps

Talk to the team behind this work.

Want to explore licensing the EmPowerPutida strain platform or connecting with the consortium's industrial partners? SciTransfer can arrange a targeted introduction to the right team members.

Order a report on this topic More in Manufacturing & Industry 4.0